Overview

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This study is an open label, prospective, randomised comparative, single center study. In the present study, the impact of a 12-week pulsatile insulin infusion therapy (PIT) with Humulin R 100 from
Phase:
Phase 4
Details
Lead Sponsor:
Sciema UG
Collaborator:
Innovative Diabetes Treatment Studies LLC.
Treatments:
Insulin
Insulin, Globin Zinc
Insulin, Isophane